Several studies have reported an association between plasma sortilin levels and cardiovascular damage and DM, which led to the idea that circulating sortilin plasma levels should be used as a potential biomarker for cardiovascular disease (CVD) and DM [101]. This evidence concerns the gene SORT1 and cardiovascular disorder.